Stock UniverseDerived research view · source repositories remain read-only

Septerna, Inc. (SEPN)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Qualified
Selection Score
37.21
Global Rank
862
Market Cap
1.30B
Latest Close
31.15
RS Composite
14.36% · G#589

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
26.06%
3M
8.23%
6M
17.33%
1Y
212.44%
3Y
45.56%
5Y
45.56%
10Y
45.56%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 205.07K · 30-day average: 323.27K · Max drawdown over stored range: -81.47%

Research Snapshot

Relative Strength vs SPX

RS Composite14.36%
20D RS29.26%
60D RS9.42%
120D RS11.85%
Global RS Rank589 · 82.44% percentile
Qualified+ RS Rank230 · 81.72% percentile
Group ScopeQualified+
Primary RS Rank78 · 82.97% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank157 / 701
Primary Percentile77.75
Score Notesmarket-cap support, industry-tailwind

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

PeriodFiledRevenueGross ProfitOperating IncomeNet IncomeEPS DilutedOperating Cash FlowCapital ExpenditureFree Cash FlowShares DilutedGross MarginOperating MarginNet MarginOCF MarginFCF MarginCash + ST Inv.Total Debt
TTM through 2025-12-312026-03-0945.95Mn/a-68.30M-48.88M-1.1043.22M1.34M41.88M45Mn/a-1.49%-1.06%94.05%91.13%391.09Mn/a

SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

TTM Valuation

PeriodEPS DilutedP/ERevenue / ShareP/SFCF / ShareP/FCF MultipleOCF / ShareP/CF Multiple
TTM through 2025-12-31$-1.10-28.4x$1.0330.2x$0.9433.2x$0.9732.1x

Shares Diluted: 45M. SEC TTM. Read-only SEC TTM snapshot. Shares Diluted is the rolling average across the four-quarter window.

Financial Statement Metrics

MetricFY 2022FY 2023FY 2024FY 2025
Revenue00.1511.075
Revenue Growth (YoY)2500%2500%611.921%
Gross Profit00.1511.075
Operating Income-27.967-45.55-80.823
Free Cash Flow-24.592-41.601-69.573109.671
Free Cash Flow Per Share-17.115-19.108-7.0342.4779737549114476
EPS (Diluted) GAAP-19.2612440.288913-7.26
EPS Growth
EPS Non-GAAP
Gross Margin2500%100%100%
Operating Margin2500%-30165.563%-7518.419%
Profit Margin2500%375.497%-6678.884%
Free Cash Flow Margin2500%-27550.331%-6471.907%
Shares Outstanding (Diluted)1.43692.17719.891144.2583
Shares Change (YoY)2500%51.518%354.321%347.455%

SEC Quarterly Fundamentals

Revenue + Operating Margin
Loading SEC quarterly chart...
Revenue Operating Margin
Quarter Filed Revenue Gross Margin Operating Income Op Margin Net Income Net Margin EPS Diluted Shares Diluted Cash + ST Inv. Total Debt Confidence
2025 Q42026-03-0924.12Mn/a-16.02M-66.44%-10.74M-44.52%-0.2444.58M391.09Mn/aprocessed
2025 Q32025-11-1021.50Mn/a2.61M12.16%8.17M38.02%0.1845.60M474.35Mn/aprocessed
2025 Q22025-08-11119.00Kn/a-28.98M-243.51%-24.84M-208.72%-0.5644.17M326.56Mn/aprocessed
2025 Q12025-05-15219.00Kn/a-25.91M-118.31%-21.48M-98.06%-0.4943.94M336.00Mn/aprocessed
2024 Q42025-03-27212.00Kn/a-24.72M-116.59%-20.67M-97.49%-0.6332.55M350.92Mn/aprocessed
2024 Q32024-11-20176.00Kn/a-22.55M-128.12%-20.52M-116.61%-8.402.44M130.53Mn/aprocessed

SEC processed quarterly CSV. Compact derived quarterly view from SEC processed CSV. Source files remain read-only in the SEC repository. EPS is as filed and may not be split-adjusted across older periods. StockAnalysis Financial Statement Metrics remain unchanged above.